• Organogenesis reported peer-reviewed results from a randomized clinical trial of Affinity in complex venous leg ulcers.
• Results were published in the Journal of Wound Care; no separate future presentation was disclosed.
• Affinity with standard care improved wound closure outcomes versus standard care alone in hard-to-heal ulcers.
• The 206-patient study supports broader clinical evidence across chronic wound types, strengthening the product’s coverage and adoption case.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organogenesis Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607271605PRIMZONEFULLFEED9798643) on July 27, 2026, and is solely responsible for the information contained therein.